WallStreetZenWallStreetZen

NASDAQ: CTNM
Contineum Therapeutics Inc Stock Ownership - Who owns Contineum Therapeutics?

Insider buying vs selling

Have Contineum Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CTNM insiders and whales buy or sell their stock.

CTNM Shareholders

What type of owners hold Contineum Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Johnson Johnson7.32%1,979,173$31.11MInsider
Versant Venture Capital Vi LP1.94%523,847$8.23MInsider
Daniel S. Lorrain0.66%179,335$2.82MInsider
Carmine N. Stengone0.04%11,612$182.54kInsider

1 of 1

CTNM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABCL40.68%47.55%Net BuyingNet Buying
ACAD71.22%28.78%Net BuyingNet Selling
ABSI29.91%39.04%Net BuyingNet Buying
ABIO4.98%95.02%
ADIL5.41%94.59%Net Buying

Contineum Therapeutics Stock Ownership FAQ

Who owns Contineum Therapeutics?

Contineum Therapeutics (NASDAQ: CTNM) is owned by 0.00% institutional shareholders, 9.96% Contineum Therapeutics insiders, and 90.04% retail investors. Johnson Johnson is the largest individual Contineum Therapeutics shareholder, owning 1.98M shares representing 7.32% of the company. Johnson Johnson's Contineum Therapeutics shares are currently valued at $31.67M.

If you're new to stock investing, here's how to buy Contineum Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.